Do PDRN and PN come from the same source?

Yes, both are extracted from the testes (gonads) of salmon and other fish species. The difference is chain length. PN consists of longer polynucleotide chains with higher molecular weight, while PDRN is composed of shorter oligonucleotide fragments. That structural difference determines their physical properties and mechanisms of action.

Is Rejuran a PN product or PDRN?

Rejuran is a PN-based skin booster. In South Korea it is classified as a medical device. PDRN, by contrast, is regulated as a pharmaceutical, placing the two in different regulatory categories despite their shared salmon DNA origin.

What does A2A receptor activation mean for skin?

The A2A adenosine receptor regulates tissue regeneration, angiogenesis, and anti-inflammatory signaling. When PDRN binds to it, the downstream effects include suppression of NF-κB inflammation pathways, upregulation of VEGF for improved blood supply, inhibition of MMP-1 collagen-degrading enzymes, and increased production of anti-inflammatory IL-10.

PDRN vs PN, What the 2026 Review Actually Found

PDRN and PN (polynucleotide) are often used interchangeably in the aesthetic medicine space. Both derive from salmon DNA, both are marketed around tissue regeneration. But a 2026 review published in the Journal of Clinical Medicine via PMC draws clear lines between the two, separating them by molecular weight, viscoelasticity, receptor binding, and clinical applications.

With the regenerative beauty sector projected to exceed $67 billion by the end of 2026, understanding what these ingredients actually do, and how they differ, has become a practical question rather than an academic one.

The molecular split

The raw material is identical. Both PDRN and PN are extracted from the testes of fish, typically salmon. What differs is chain length.

PN (polynucleotide): Composed of longer DNA polymer chains with higher molecular weight. Greater viscoelasticity means it behaves more like a gel, providing structural support within the dermis. This property makes PN particularly effective as a structural skin booster.

PDRN (polydeoxyribonucleotide): Shorter oligonucleotide fragments with lower molecular weight. More fluid in consistency, it diffuses through tissue more readily and has pharmacological characteristics more similar to a drug than a device.

South Korean regulatory classification reflects this distinction. PN is categorized as a medical device; PDRN is classified as a pharmaceutical.

How PDRN works, two pathways at once

PDRN operates through two simultaneous mechanisms that set it apart from simple structural fillers.

Pathway 1: A2A adenosine receptor activation. The A2A receptor controls tissue repair, angiogenesis (new blood vessel formation), and the suppression of inflammatory signals. PDRN binding to this receptor triggers a downstream cascade:

Suppression of NF-κB and MAPK signaling, two of the main inflammation amplifiers
Downregulation of MMP-1, the enzyme that degrades existing collagen
Upregulation of VEGF, improving oxygen and nutrient delivery to the tissue
Increased IL-10, an anti-inflammatory cytokine

Pathway 2: The salvage pathway. PDRN’s nucleotide building blocks are recycled by cells as raw material for DNA synthesis. Rather than just signaling regeneration from the outside, PDRN supplies the molecular components cells need to rebuild from the inside.

For collagen specifically, PDRN promotes expression of both type I and type III collagen via ERK signaling. Type I collagen contributes to skin density; type III to elasticity and flexibility. The review also confirmed PDRN’s melanogenesis-inhibiting effect through tyrosinase suppression, making it relevant for pigmentation concerns alongside its regenerative applications.

PN’s clinical edge

Head-to-head comparisons between PN and hyaluronic acid favor PN on several measurable outcomes: skin roughness, pore size, and hydration retention all showed superior improvement with PN treatment. Rejuran is the best-known commercial PN product in the aesthetic market.

The higher viscoelasticity of PN means it does more than simply fill space. It creates a scaffold-like structure that supports tissue architecture while the skin’s own repair processes take over.

The direction regenerative beauty is heading

Both ingredients represent the broader regenerative philosophy in aesthetic medicine: rather than replacing volume or freezing muscle, the goal is to signal the skin’s own cells to rebuild. PDRN, polynucleotides, and exosomes are now moving from clinic-only treatments into consumer product formulations, with Asia-Pacific markets leading the adoption curve.

The 2026 review provides a framework for distinguishing between these ingredients as they become more mainstream, and for matching the right approach to the right clinical goal.

Sources

PMC / Journal of Clinical Medicine (2026). Comparative review of PDRN and polynucleotide in regenerative aesthetics.

Source: PMC / Journal of Clinical Medicine